MUC1 Glycopeptide Array

10615

From: $1,440.00

The MUC1 glycopeptide array allows researchers to screen a large MUC1 glycopeptide library. The current MUC1 glycopeptide array includes 62 MUC1 glycopeptides and 1 unglycosylated control peptide. Each glycopeptide is 23-mer in length and modified with Tn (GalNAc-Ser or -Thr) or STn (Neu5Ac-6-GalNAc-Ser or -Thr). This microarray allows researchers to identify, profile, and compare specific antibody responses and detect and validate protein interactions with various MUC1 glycoforms. This array is highly sensitive with low background. The MUC1 glycopeptide array can be customized to meet individual client needs. Assay services are available upon request. We also provide services to synthesize various MUC1 glycopeptides.

SKU: 10615 Category:
Description
Structures
Examples
Document

Description

Mucin 1 (MUC1) is a transmembrane glycoprotein. It is one of the several proteins that make up mucus. The extracellular domain of MUC1 comprises a variable number of 20-amino-acid tandem repeats that are highly O-glycosylated. In each O-glycosite, α-N-acetylgalactosamine (GalNAc, Tn) is first attached to the hydroxyl group of threonine (Thr) and serine (Ser) of the tandem repeats, which are further extended with galactose (Gal), N-acetylglucosamine (GlcNAc), or GalNAc to form eight different core structures. These structures can be further modified by sialylation, sulfation, acetylation, fucosylation, and polylactosamine extensions.

MUC1 is expressed on the surface of normal epithelial cells, and changes in glycosylation patterns occur in various pathological conditions. For example, aberrant glycosylation of MUC1 prevents cancer cells from forming core 2-based glycans. Therefore, cancer-associated MUC1 is hypoglycosylated with short carbohydrate structures such as Tn (GalNAc-Ser or -Thr) and STn (Neu5Ac-6-GalNAc-Thr). This unique feature makes MUC1 an ideal cancer-specific antigen for therapeutic development.

Z Biotech has developed a robust microarray platform that allows researchers to screen a large MUC1 glycopeptide library. The current MUC1 glycopeptide array includes 62 MUC1 glycopeptides and 1 unglycosylated control peptide. Each glycopeptide is 23-mer in length and modified with Tn (GalNAc-Ser or -Thr) or STn (Neu5Ac-6-GalNAc-Ser or -Thr). This microarray allows researchers to identify, profile, and compare specific antibody responses and detect and validate protein interactions with various MUC1 glycoforms. This array is highly sensitive with low background. The MUC1 glycopeptide array can be customized to meet individual client needs. Assay services are available upon request. We also provide services to synthesize various MUC1 glycopeptides.

Features

  • Unrivaled sensitivity and specificity;
  • Simple assay format;
  • Small sample volume;
  • Customizable (select MUC1 peptides and/or glycopeptides for a specific microarray format)
  • Assay service available;

Applications

  • Serological screening of disease-associated autoantibodies binding to MUC1 glycopeptides;
  • Map unique MUC1 glycopeptide epitopes to determine carbohydrate specificities of antibodies;
  • Evaluate binding specificities of MUC1-interacting proteins, vesicles, cells, and viral particles.

Structures

List of MUC1 glycopeptide sequences on the array (download the PDF)

# Sequence
1 PPAHGVT(GalNAc)SAPDTRPAPGSTAPPA
2 PPAHGVTS(GalNAc)APDTRPAPGSTAPPA
3 PPAHGVTSAPDT(GalNAc)RPAPGSTAPPA
4 PPAHGVTSAPDTRPAPGS(GalNAc)TAPPA
5 PPAHGVTSAPDTRPAPGST(GalNAc)APPA
6 PPAHGVT(GalNAc)S(GalNAc)APDTRPAPGSTAPPA
7 PPAHGVT(GalNAc)SAPDT(GalNAc)RPAPGSTAPPA
8 PPAHGVT(GalNAc)SAPDTRPAPGS(GalNAc)TAPPA
9 PPAHGVT(GalNAc)SAPDTRPAPGST(GalNAc)APPA
10 PPAHGVTS(GalNAc)APDT(GalNAc)RPAPGSTAPPA
11 PPAHGVTS(GalNAc)APDTRPAPGS(GalNAc)TAPPA
12 PPAHGVTS(GalNAc)APDTRPAPGST(GalNAc)APPA
13 PPAHGVTSAPDT(GalNAc)RPAPGS(GalNAc)TAPPA
14 PPAHGVTSAPDT(GalNAc)RPAPGST(GalNAc)APPA
15 PPAHGVTSAPDTRPAPGS(GalNAc)T(GalNAc)APPA
16 PPAHGVT(GalNAc)S(GalNAc)APDT(GalNAc)RPAPGSTAPPA
17 PPAHGVT(GalNAc)S(GalNAc)APDTRPAPGS(GalNAc)TAPPA
18 PPAHGVT(GalNAc)S(GalNAc)APDTRPAPGST(GalNAc)APPA
19 PPAHGVT(GalNAc)SAPDT(GalNAc)RPAPGS(GalNAc)TAPPA
20 PPAHGVT(GalNAc)SAPDT(GalNAc)RPAPGST(GalNAc)APPA
21 PPAHGVT(GalNAc)SAPDTRPAPGS(GalNAc)T(GalNAc)APPA
22 PPAHGVTS(GalNAc)APDT(GalNAc)RPAPGS(GalNAc)TAPPA
23 PPAHGVTS(GalNAc)APDT(GalNAc)RPAPGST(GalNAc)APPA
24 PPAHGVTS(GalNAc)APDTRPAPGS(GalNAc)T(GalNAc)APPA
25 PPAHGVTSAPDT(GalNAc)RPAPGS(GalNAc)T(GalNAc)APPA
26 PPAHGVT(GalNAc)S(GalNAc)APDT(GalNAc)RPAPGS(GalNAc)TAPPA
27 PPAHGVT(GalNAc)S(GalNAc)APDT(GalNAc)RPAPGST(GalNAc)APPA
28 PPAHGVT(GalNAc)S(GalNAc)APDTRPAPGS(GalNAc)T(GalNAc)APPA
29 PPAHGVT(GalNAc)SAPDT(GalNAc)RPAPGS(GalNAc)T(GalNAc)APPA
30 PPAHGVTS(GalNAc)APDT(GalNAc)RPAPGS(GalNAc)T(GalNAc)APPA
31 PPAHGVT(GalNAc)S(GalNAc)APDT(GalNAc)RPAPGS(GalNAc)T(GalNAc)APPA
32 PPAHGVT(Neu5Ac-6-GalNAc)SAPDTRPAPGSTAPPA
33 PPAHGVTS(Neu5Ac-6-GalNAc)APDTRPAPGSTAPPA
34 PPAHGVTSAPDT(Neu5Ac-6-GalNAc)RPAPGSTAPPA
35 PPAHGVTSAPDTRPAPGS(Neu5Ac-6-GalNAc)TAPPA
36 PPAHGVTSAPDTRPAPGST(Neu5Ac-6-GalNAc)APPA
37 PPAHGVT(Neu5Ac-6-GalNAc)S(Neu5Ac-6-GalNAc)APDTRPAPGSTAPPA
38 PPAHGVT(Neu5Ac-6-GalNAc)SAPDT(Neu5Ac-6-GalNAc)RPAPGSTAPPA
39 PPAHGVT(Neu5Ac-6-GalNAc)SAPDTRPAPGS(Neu5Ac-6-GalNAc)TAPPA
40 PPAHGVT(Neu5Ac-6-GalNAc)SAPDTRPAPGST(Neu5Ac-6-GalNAc)APPA
41 PPAHGVTS(Neu5Ac-6-GalNAc)APDT(Neu5Ac-6-GalNAc)RPAPGSTAPPA
42 PPAHGVTS(Neu5Ac-6-GalNAc)APDTRPAPGS(Neu5Ac-6-GalNAc)TAPPA
43 PPAHGVTS(Neu5Ac-6-GalNAc)APDTRPAPGST(Neu5Ac-6-GalNAc)APPA
44 PPAHGVTSAPDT(Neu5Ac-6-GalNAc)RPAPGS(Neu5Ac-6-GalNAc)TAPPA
45 PPAHGVTSAPDT(Neu5Ac-6-GalNAc)RPAPGST(Neu5Ac-6-GalNAc)APPA
46 PPAHGVTSAPDTRPAPGS(Neu5Ac-6-GalNAc)T(Neu5Ac-6-GalNAc)APPA
47 PPAHGVT(Neu5Ac-6-GalNAc)S(Neu5Ac-6-GalNAc)APDT(Neu5Ac-6-GalNAc)RPAPGSTAPPA
48 PPAHGVT(Neu5Ac-6-GalNAc)S(Neu5Ac-6-GalNAc)APDTRPAPGS(Neu5Ac-6-GalNAc)TAPPA
49 PPAHGVT(Neu5Ac-6-GalNAc)S(Neu5Ac-6-GalNAc)APDTRPAPGST(Neu5Ac-6-GalNAc)APPA
50 PPAHGVT(Neu5Ac-6-GalNAc)SAPDT(Neu5Ac-6-GalNAc)RPAPGS(Neu5Ac-6-GalNAc)TAPPA
51 PPAHGVT(Neu5Ac-6-GalNAc)SAPDT(Neu5Ac-6-GalNAc)RPAPGST(Neu5Ac-6-GalNAc)APPA
52 PPAHGVT(Neu5Ac-6-GalNAc)SAPDTRPAPGS(Neu5Ac-6-GalNAc)T(Neu5Ac-6-GalNAc)APPA
53 PPAHGVTS(Neu5Ac-6-GalNAc)APDT(Neu5Ac-6-GalNAc)RPAPGS(Neu5Ac-6-GalNAc)TAPPA
54 PPAHGVTS(Neu5Ac-6-GalNAc)APDT(Neu5Ac-6-GalNAc)RPAPGST(Neu5Ac-6-GalNAc)APPA
55 PPAHGVTS(Neu5Ac-6-GalNAc)APDTRPAPGS(Neu5Ac-6-GalNAc)T(Neu5Ac-6-GalNAc)APPA
56 PPAHGVTSAPDT(Neu5Ac-6-GalNAc)RPAPGS(Neu5Ac-6-GalNAc)T(Neu5Ac-6-GalNAc)APPA
57 PPAHGVT(Neu5Ac-6-GalNAc)S(Neu5Ac-6-GalNAc)APDT(Neu5Ac-6-GalNAc)RPAPGS(Neu5Ac-6-GalNAc)TAPPA
58 PPAHGVT(Neu5Ac-6-GalNAc)S(Neu5Ac-6-GalNAc)APDT(Neu5Ac-6-GalNAc)RPAPGST(Neu5Ac-6-GalNAc)APPA
59 PPAHGVT(Neu5Ac-6-GalNAc)S(Neu5Ac-6-GalNAc)APDTRPAPGS(Neu5Ac-6-GalNAc)T(Neu5Ac-6-GalNAc)APPA
60 PPAHGVT(Neu5Ac-6-GalNAc)SAPDT(Neu5Ac-6-GalNAc)RPAPGS(Neu5Ac-6-GalNAc)T(Neu5Ac-6-GalNAc)APPA
61 PPAHGVTS(Neu5Ac-6-GalNAc)APDT(Neu5Ac-6-GalNAc)RPAPGS(Neu5Ac-6-GalNAc)T(Neu5Ac-6-GalNAc)APPA
62 PPAHGVT(Neu5Ac-6-GalNAc)S(Neu5Ac-6-GalNAc)APDT(Neu5Ac-6-GalNAc)RPAPGS(Neu5Ac-6-GalNAc)T(Neu5Ac-6-GalNAc)APPA
63 PPAHGVTSAPDTRPAPGSTAPPA

Examples

Using MUC1 glycopeptide array to determine the binding specificity of Bauhinia purpurea agglutinin (BPL) lectin

The MUC1 glycopeptide array was assayed with biotinylated Bauhinia purpurea agglutinin (BPL) lectin (10 μg/mL), followed by streptavidin (Cy3). The array was scanned with a microarray scanner at 532nm wavelength. Positive control showed binding signals as expected. BPL binds to MUC1 glycopeptides decorated with Tn antigens.

Using MUC1 glycopeptide array to determine the binding specificity of an anti-sTn antibody.

The MUC1 glycopeptide array was assayed with an anti-sTn antibody, followed by a secondary antibody (Cy5) for detection. The array was scanned with a microarray scanner at 532nm and 647nm. Positive control showed binding signals as expected. Anti-sTn antibody binds to MUC1 glycopeptides with unique sTn decorations.

Document

List of MUC1 glycopeptide sequences on the array  (download the PDF)

Protocol & User Manual (download the manual)